rs55868891

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001353921.2(ARHGEF9):​c.49A>G​(p.Ile17Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,209,553 control chromosomes in the GnomAD database, including 1 homozygotes. There are 48 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., 30 hem., cov: 22)
Exomes 𝑓: 0.000087 ( 0 hom. 18 hem. )

Consequence

ARHGEF9
NM_001353921.2 missense

Scores

1
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.35

Publications

1 publications found
Variant links:
Genes affected
ARHGEF9 (HGNC:14561): (Cdc42 guanine nucleotide exchange factor 9) The protein encoded by this gene is a Rho-like GTPase that switches between the active (GTP-bound) state and inactive (GDP-bound) state to regulate CDC42 and other genes. This brain-specific protein also acts as an adaptor protein for the recruitment of gephyrin and together these proteins facilitate receceptor recruitement in GABAnergic and glycinergic synapses. Defects in this gene are the cause of startle disease with epilepsy (STHEE), also known as hyperekplexia with epilepsy, as well as several other types of cognitive disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
ARHGEF9 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 8
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00862357).
BP6
Variant X-63724693-T-C is Benign according to our data. Variant chrX-63724693-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 128450.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 30 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGEF9NM_001353921.2 linkc.49A>G p.Ile17Val missense_variant Exon 2 of 10 ENST00000671741.2 NP_001340850.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGEF9ENST00000671741.2 linkc.49A>G p.Ile17Val missense_variant Exon 2 of 10 NM_001353921.2 ENSP00000500715.1 A0A5F9ZHY9

Frequencies

GnomAD3 genomes
AF:
0.00116
AC:
129
AN:
111474
Hom.:
1
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00412
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000284
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000218
AC:
40
AN:
183125
AF XY:
0.0000740
show subpopulations
Gnomad AFR exome
AF:
0.00296
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000865
AC:
95
AN:
1098023
Hom.:
0
Cov.:
30
AF XY:
0.0000495
AC XY:
18
AN XY:
363389
show subpopulations
African (AFR)
AF:
0.00326
AC:
86
AN:
26400
American (AMR)
AF:
0.0000568
AC:
2
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30201
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54141
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40491
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4115
European-Non Finnish (NFE)
AF:
0.00000238
AC:
2
AN:
841994
Other (OTH)
AF:
0.000108
AC:
5
AN:
46090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00116
AC:
129
AN:
111530
Hom.:
1
Cov.:
22
AF XY:
0.000890
AC XY:
30
AN XY:
33718
show subpopulations
African (AFR)
AF:
0.00411
AC:
126
AN:
30665
American (AMR)
AF:
0.000284
AC:
3
AN:
10559
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3538
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2603
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6035
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53076
Other (OTH)
AF:
0.00
AC:
0
AN:
1510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000459
Hom.:
21
Bravo
AF:
0.00122
ESP6500AA
AF:
0.00469
AC:
18
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000222
AC:
27

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 26, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Dec 29, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy, 8 Benign:1
Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
19
DANN
Benign
0.43
DEOGEN2
Benign
0.070
T;T;.;.;.;T
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.81
T;T;T;T;T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.0086
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.41
N;.;.;.;.;.
PhyloP100
2.3
PROVEAN
Benign
0.67
N;.;.;.;.;.
REVEL
Benign
0.048
Sift
Benign
1.0
T;.;.;.;.;.
Sift4G
Benign
1.0
T;T;T;T;.;.
Polyphen
0.0
B;.;.;.;.;.
Vest4
0.17
MVP
0.45
MPC
0.84
ClinPred
0.0074
T
GERP RS
4.0
Varity_R
0.090
gMVP
0.78
Mutation Taster
=289/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55868891; hg19: chrX-62944573; API